PREVALENCE OF TRADITIONAL RISK FACTORS FOR TYPE 2 DIABETES MELLITUS IN PATIENTS WITH RHEUMATOID ARTHRITIS
- Authors: KONDRATIEVA L.V.1, POPKOVA T.V.1, NASONOV Y.L.1
-
Affiliations:
- Issue: No 4 (2017)
- Pages: 30-34
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277651
- ID: 277651
Cite item
Open Access
Access granted
Abstract
The purpose was to clarify the prevalence of traditional risk factors (RFs) and calculate the 10-year risk of developing type 2 diabetes mellitus (DM2) in patients with rheumatoid arthritis (RA). The study included 418 patients with RA and 100 controls without inflammatory joint diseases, without a previously established diagnosis of DM1 or DM2. The presence of traditional RFs was assessed using the Finnish Type 2 Diabetes Risk Assessment Form (FINDRISK). There were an average 4 RFs per patient, and the most common modifiable RFs were abdominal obesity (AO) (64%) and insufficient physical activity (70%). At the same time, AO in RA patients was noted less frequently than in healthy controls. The prevalence of other RFs in RA patients and controls was not significantly different. The 10-year risk of developing DM2 was «moderate» in 20.1% and «high»/«very high» in 22.3% of RA patients, which is comparable to the data obtained in the control group. The prevalence of the majority of traditional RFs and the 10-year risk of developing DM2 in RA are comparable to those in controls without inflammatory joint diseases. The FINDRISK questionnaire is a simple method for identifying patients with RA who need to follow-up and change their lifestyle, as well as an additional examination to exclude subclinical DM2.
Full Text
About the authors
Lyubov V. KONDRATIEVA
Email: kondratyeva.liubov@yandex.ru
PhD, senior researcher, V.A. Nasonova Research Institute of Rheumatology 115522, Moscow, 34A Kashirskoe shosse
Tatiana V. POPKOVA
Email: popkovatv@mail.ru
MD, head of the Laboratory of systemic rheumatic diseases with a group of hemorheological disorders, V.A. Nasonova Research Institute of Rheumatology 115522, Moscow, 34A Kashirskoe shosse
Yevgeny L. NASONOV
academician of RAS, MD, professor, president of Russian Association of Rheumatologists, chief freelance specialist in rheumatology of Ministry of Health of Russia, V.A. Nasonova Research Institute of Rheumatology. 115522, Moscow, 34A Kashirskoe shosse
References
- Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104-12. [Dedov I.I., Shestakova M.V., Galstyan G.R. Prevalence of diabetes type 2 in the adult population of Russia (NATION study). Diabetes mellitus. 2016;19(2):104-12 (in Russ.)]
- Lindstrom J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003:26(3):725-31.
- Дедов И.И., Шестакова М.В., Александров А.А. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (5-й выпуск). Сахарный диабет. 2011;(3s):2-72. [Dedov I.I., Shestakova M.V., Aleksandrov A.A., et al. Algorithms of specialized medical care for diabetes mellitus patients (5th ed.). Diabetes mellitus. 2011;(3s):2-72 (in Russ.)]
- Насонов Е.Л. (ред.) Ревматология. Клинические рекомендации. М.: ГЭОТАР-Медиа, 2010. [Nasonov Ye.L. (ed). Rheumatology. Clinical guidelines. Moscow: GEOTAR-Media, 2010]
- Solomon D.H., Love T.J., Canning C., Schneeweiss S. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann. Rheum. Dis. 2010;69(12):2114-7.
- Dessein P.H., Joffe B.I. Insulin resistance and impaired beta-cell function in rheumatoid arthritis. Arthritis Rheum. 2006;54(9):2765-75.
- Hoes J.N., van der Goes M.C., van Raalt D.H., van der Zijl N.J., den Uyl D., Lems W.F., Lafeber F.P., Jacobs J.W., Welsing P.M., Diamant M., Bijlsma J.W. Glucose tolerance, insulin sensitivity and ß-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann. Rheum. Dis. 2011;70:1887-94.
- Wolf F., Michaud K. The effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res. 2012; 64(10):1471-9.
- Ajeganova S., Andersson M.L., Hafstrom I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long-term follow-up from disease onset. Arthritis Care Res. 2013;65(1):78-87.
- Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006;6 (10):772-83.
- Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell Endocrinol. 2010;316(2):129-39.
- Мустафина С.В., Рымар О.Д., Сазонова О.В. и др. Валидизация финской шкалы риска «FINDRISC» на европеоидной популяции Сибири. Сахарный диабет. 2016;19(2):113-8. [Mustafina S.V., Rymar O.D., Sazonova O.V. et al. Validation of Finnish risk score «FINDRISC» on the European population of Siberia. Diabetes mellitus. 2016;19(2):113-8 (in Russ.)]
Supplementary files
